Unknown

Dataset Information

Inhibiting CBX4 efficiently protects hepatocellular carcinoma cells against sorafenib resistance.


ABSTRACT:

Background

This study aimed to investigate the possible role of inhibiting chromobox protein homologue 4 (CBX4) to deregulate of cancer stem cells (CSCs) and to evaluate the contribution of these molecules to sorafenib resistance in advanced hepatocellular carcinoma (HCC).

Methods

HCC cell lines and a xenograft mouse model with resistance to sorafenib were employed to analyse the effects of miR424 on CSC characteristics. RNA expression was analysed by RT-PCR and next-generation sequencing in a cohort of HCC cancer patients and sorafenib-resistant (SR) cell lines, respectively, to validate the key microRNAs and targets in the network.

Results

MicroRNA and mRNA profiles of SR cell lines identified miR424 and its direct target CBX4 as significantly associated with stem-c

SUBMITTER: Zhao W 

PROVIDER: S-EPMC8007794 | biostudies-literature | 2021 Mar

REPOSITORIES: biostudies-literature